RY 169.51 -1.1719% SHOP 175.85 -3.2036% TD 85.4 -0.187% ENB 59.6 -1.715% BN 84.78 -1.4873% TRI 250.65 2.1186% CNQ 43.69 0.9007% CP 110.72 -0.5926% CNR 146.88 0.7891% BMO 142.84 -0.6054% BNS 72.34 -0.0829% CSU 4896.4902 0.1981% CM 87.07 -0.9668% MFC 45.08 6.5217% ATD 71.13 -0.6425% NGT 68.13 0.9932% TRP 64.42 -1.2872% SU 56.73 -0.0176% WCN 266.69 -0.146% L 176.74 -1.5157%
Last update at 2025-02-20T19:04:00Z
Why Tempus AI (TEM) Crashed on Tuesday?
Wed 19 Feb 25, 08:58 PMAres Management Upsizes Tempus Debt Facilities to $560 Million
Tue 18 Feb 25, 09:30 PMWhy Tempus AI, Inc. (TEM) Soared Last Week
Mon 17 Feb 25, 12:49 PMWhy Tempus AI Inc. (TEM) Went Up on Thursday
Fri 14 Feb 25, 03:38 AMCatherine Wood's Strategic Moves: Tesla Inc. Sees a Significant Reduction
Wed 05 Feb 25, 03:01 PMWhy Tempus AI Stock Skyrocketed Nearly 22% Today
Wed 21 Aug 24, 10:13 PM7 Growth Stocks to Buy on Corrections for 3X Returns by 2026
Thu 15 Aug 24, 10:10 AMRon Baron's Strategic Moves in Q2 2024: A Closer Look at Tesla's Position Adjustment
Wed 14 Aug 24, 11:04 PM| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Income before tax | -213.83000M | -289.15000M | -258.58800M | -211.35400M |
| Minority interest | - | - | - | - |
| Net income | -214.11800M | -289.81100M | -259.19200M | -209.85400M |
| Selling general administrative | 296.76M | 233.38M | 199.00M | 130.89M |
| Selling and marketing expenses | - | - | - | - |
| Gross profit | 286.18M | 121.68M | 77.39M | 22.83M |
| Reconciled depreciation | 33.33M | 30.41M | 23.88M | 23.05M |
| Ebit | -166.66000M | -267.25600M | -243.40400M | -192.42500M |
| Ebitda | -133.32800M | -236.84600M | -219.52300M | -169.37300M |
| Depreciation and amortization | 33.33M | 30.41M | 23.88M | 23.05M |
| Non operating income net other | - | - | - | - |
| Operating income | -196.08300M | -269.14300M | -243.97900M | -193.93200M |
| Other operating expenses | 727.90M | 589.81M | 501.83M | 381.94M |
| Interest expense | 46.87M | 21.89M | 15.18M | 18.93M |
| Tax provision | 0.29M | 0.07M | 0.00000M | 0.00000M |
| Interest income | 7.60M | 3.03M | 0.62M | 1.50M |
| Net interest income | -39.26800M | -18.86200M | -14.56100M | -17.43400M |
| Extraordinary items | - | - | - | - |
| Non recurring | - | - | - | - |
| Other items | - | - | - | - |
| Income tax expense | 0.29M | 0.07M | 0.60M | -1.50000M |
| Total revenue | 531.82M | 320.67M | 257.85M | 188.00M |
| Total operating expenses | 482.26M | 390.82M | 321.37M | 216.76M |
| Cost of revenue | 245.65M | 198.99M | 180.46M | 165.18M |
| Total other income expense net | -17.74700M | -23.70800M | -14.60900M | -17.90000M |
| Discontinued operations | - | - | - | - |
| Net income from continuing ops | -214.11800M | -289.81100M | -259.19200M | -209.85400M |
| Net income applicable to common shares | - | - | - | - |
| Preferred stock and other adjustments | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 564.05M | 631.36M | 531.35M | 751.92M | - |
| Intangible assets | 21.92M | 37.28M | 37.29M | 44.46M | - |
| Earning assets | - | - | - | - | - |
| Other current assets | 24.61M | 19.45M | 17.29M | 11.48M | - |
| Total liab | 1946.21M | 734.25M | 440.55M | 405.75M | - |
| Total stockholder equity | -1382.16300M | -102.88400M | 90.80M | 346.17M | - |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 171.77M | 71.75M | 64.18M | 48.11M | - |
| Common stock | 0.00600M | 0.00600M | 0.00600M | 0.00600M | - |
| Capital stock | 0.00600M | 0.00600M | 0.00600M | 0.00600M | - |
| Retained earnings | -1396.91700M | -1138.30200M | -807.48600M | -512.98900M | - |
| Other liab | - | - | - | - | - |
| Good will | 73.35M | 53.10M | 15.98M | 15.99M | - |
| Other assets | - | - | - | 0.00000M | - |
| Cash | 165.77M | 302.94M | 277.69M | 513.44M | - |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 232.63M | 174.24M | 114.81M | 109.37M | - |
| Current deferred revenue | 64.86M | 50.14M | 16.45M | 6.96M | - |
| Net debt | 322.38M | 130.09M | -38.74000M | -261.98900M | - |
| Short term debt | 6.44M | 6.36M | 0.42M | 0.72M | - |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 488.14M | 433.03M | 238.95M | 251.45M | - |
| Other stockholder equity | -1090.80000M | 9.25M | - | - | - |
| Property plant equipment | - | - | - | - | - |
| Total current assets | 350.33M | 433.35M | 400.13M | 649.73M | - |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | - | - |
| Short term investments | 31.81M | 0.00000M | - | - | - |
| Net receivables | 99.31M | 88.68M | 82.24M | 87.26M | - |
| Long term debt | 449.67M | 389.55M | 238.24M | 250.00M | - |
| Inventory | 28.84M | 22.28M | 22.91M | 37.56M | - |
| Accounts payable | 54.42M | 45.99M | 33.75M | 53.57M | - |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 0.00500M | 0.02M | -0.01100M | -0.00100M | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 36.24M | 14.11M | 10.71M | 2.52M | - |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 213.72M | 198.01M | 131.22M | 102.19M | - |
| Capital lease obligations | 38.48M | 43.48M | 0.71M | 1.45M | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -40.31300M | -57.93900M | -21.72400M | -13.41600M | - |
| Change to liabilities | - | - | - | - | - |
| Total cashflows from investing activities | - | - | - | - | - |
| Net borrowings | - | - | - | - | - |
| Total cash from financing activities | 117.55M | 251.39M | -2.03900M | 506.11M | - |
| Change to operating activities | - | - | - | - | - |
| Net income | -214.11800M | -289.81100M | -259.19200M | -209.85400M | - |
| Change in cash | -137.12400M | 25.25M | -235.75000M | 285.34M | - |
| Begin period cash flow | 303.73M | 277.69M | 513.44M | 228.10M | - |
| End period cash flow | 166.61M | 302.94M | 277.69M | 513.44M | 228.10M |
| Total cash from operating activities | -214.33900M | -168.20400M | -211.98400M | -206.56200M | - |
| Issuance of capital stock | 44.88M | 92.20M | 8.89M | 189.93M | - |
| Depreciation | 33.33M | 30.41M | 23.88M | 23.05M | - |
| Other cashflows from investing activities | - | - | -4.00000M | - | - |
| Dividends paid | 5.62M | 5.62M | 5.62M | 5.62M | - |
| Change to inventory | -6.56300M | -1.31200M | 14.65M | -29.27800M | - |
| Change to account receivables | -7.34700M | -8.20300M | 4.75M | -55.84400M | - |
| Sale purchase of stock | -3.60200M | 0.00000M | 0.00000M | -7.31100M | - |
| Other cashflows from financing activities | 44.19M | 86.77M | 4.38M | 189.93M | - |
| Change to netincome | - | - | - | - | - |
| Capital expenditures | 34.61M | 18.38M | 11.77M | 13.42M | 0.00000M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -37.83700M | 71.82M | 14.55M | -28.56000M | - |
| Stock based compensation | - | 0.00000M | 0.56M | 0.40M | 0.53M |
| Other non cash items | 4.28M | 97.63M | 67.62M | 101.89M | - |
| Free cash flow | -248.94700M | -186.58100M | -223.75100M | -219.97800M | - |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | |
|---|---|---|---|---|---|---|---|---|
| TEM Tempus AI, Inc. Class A Common Stock |
-9.26 10.80% | 76.45 | - | - | 13.29 | 80.58 | 13.27 | |
| GEHC GE HealthCare Technologies Inc. |
-0.57 0.62% | 91.95 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-0.64 0.28% | 228.55 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 9.45 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
0.29 4.68% | 6.48 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a collaboration with united therapeutics to study use of AI to detect patients at risk for pulmonary hypertension. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
600 West Chicago Avenue, Chicago, IL, United States, 60654
| Name | Title | Year Born |
|---|---|---|
| Mr. Eric P. Lefkofsky | Co-Founder, CEO, President & Chairman | 1970 |
| Mr. James Rogers | Chief Financial Officer | 1986 |
| Mr. Ryan Fukushima | Chief Operating Officer | 1985 |
| Mr. Ryan M. Bartolucci CPA | Chief Accounting Officer | 1982 |
| Mr. Shane Colley | Chief Technology Officer | NA |
| Dr. Kate A. Sasser Ph.D. | Chief Scientific Officer | 1977 |
| Mr. Erik Phelps | Executive VP, Assistant Secretary and Chief Administrative & Legal Officer | 1971 |
| Ms. Patty Spiller | Senior Vice President of Marketing | NA |
| Ms. Christina Antoniou | Senior VP & Head of Corporate Development | NA |
| Ms. Stacey Kraft | Chief People Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...